A 33-Year-Old Man With Dyspnea, Chest Pain, and a Massive Pleural Effusion

Hawkins, Padraig; Doyle, Aoife; Gavin, Leo; Fabre, Aurélie; Murphy, David J.; Dunican, Eleanor M.; McCarthy, Cormac

doi:10.1016/j.chest.2020.08.2102

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The presence of MPE indicates that the primary tumor has spread to the pleura or has progressed to an advanced stage, and the survival of patients is significantly shortened. Once MPE is diagnosed in patients with tumors, it should be actively treated; otherwise, the accumulation of fluid will cause pulmonary atelectasis or recurrent lung infections and even threaten the life of the patient ( 13 ). With advances in medical technology and in-depth research on the pathogenesis of MPE, innovative drugs and treatment strategies have been developed.…”

Section: Introductionmentioning

confidence: 99%

Current status of and progress in the treatment of malignant pleural effusion of lung cancer

Zhao

Wang

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

Malignant pleural effusion (MPE) is a common complication in the late stage of malignant tumors. The appearance of MPE indicates that the primary tumor has spread to the pleura or progressed to an advanced stage. The survival time of the patients will be significantly shortened, with a median survival of only a few months. There are a variety of traditional treatments, and their advantages and disadvantages are relatively clear. There are still many problems that cannot be solved by traditional methods in clinical work. The most common one is intrapleural perfusion therapy with chemotherapy drugs, but it has a large side effect of chemotherapy. At present, with the development of medical technology, there are a variety of treatment methods, and many innovative, significant and valuable treatment methods have emerged, which also bring hope for the treatment of refractory and recurrent MPE patients. Several clinical trials had confirmed that drug-carrying microparticles has less adverse reactions and obvious curative effect. However, there is still a long way to go to completely control and cure MPE, and the organic combination of clinical work and scientific research results is needed to bring dawn to refractory MPE patients.

show abstract

Section: Introductionmentioning

confidence: 99%